search
Back to results

Physical Activity and Testicular Cancer

Primary Purpose

Testicular Cancer

Status
Completed
Phase
Not Applicable
Locations
Norway
Study Type
Interventional
Intervention
Physical activity counseling
Sponsored by
Oslo University Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Testicular Cancer focused on measuring Physical activity, Testicular cancer, Chemotherapy, Feasibility

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)MaleDoes not accept healthy volunteers

Inclusion Criteria:

  • Seminoma/non-seminoma
  • Stage II-IV
  • 3-4 BEP(bleomycin,etoposide and cisplatin)or 4 EP(etoposide and cisplatin)
  • > 18 years
  • Capable of reading and writing Norwegian

Exclusion Criteria:

  • Conditions of a severity that contraindicate exercise without adjusted actions
  • Mentally incompetent conditions
  • Conditions of a severity that complicates the ability to participate in a supervised training program

Sites / Locations

  • Oslo university hospital

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Physical activity counseling

Arm Description

Outcomes

Primary Outcome Measures

Muscle strength, 1RM (one-repetition-maximum)
Change in 1RM from baseline to post-intervention and follow-up

Secondary Outcome Measures

Cardio respiratory fitness (VO2max)
Change in VO2max from baseline to post-intervention and follow-up
Body composition (Lean body mass and fat mass)
Change in body composition from baseline to post-intervention and follow-up
Metabolic disease markers (blood pressure, body mass index, glucose, high density lipoprotein cholesterol, triglycerides)
Change in metabolic disease markers from baseline to post-intervention and follow-up
C-reactive protein (CRP)
Change in CRP from baseline to post-intervention and follow-up
Creatinkinase (CK)
Change in CK from baseline to post-intervention and follow-up
Creatinkinase - MB (CK-MB)
Change in CK-MB from baseline to post-intervention and follow-up
Myoglobin
Change in myoglobin from baseline to post-intervention and follow-up
Work status
Change in work status from baseline to post-intervention and follow-up
Fatigue
Change in fatigue from baseline to post-intervention and follow-up
Anxiety and depression
Change in anxiety and depression from baseline to post-intervention and follow-up
Quality of life
Change in quality of life from baseline to post-intervention and follow-up

Full Information

First Posted
November 30, 2012
Last Updated
October 15, 2014
Sponsor
Oslo University Hospital
Collaborators
Norwegian School of Sport Sciences, Gjensidigestiftelsen, The Research Council of Norway
search

1. Study Identification

Unique Protocol Identification Number
NCT01749774
Brief Title
Physical Activity and Testicular Cancer
Official Title
Physical Activity and Testicular Cancer - a Pilot Study: Feasibility and Effects of a Program Including Information, Counseling and a Physical Activity Program for Patients With Testicular Cancer During and After Chemotherapy
Study Type
Interventional

2. Study Status

Record Verification Date
October 2014
Overall Recruitment Status
Completed
Study Start Date
December 2012 (undefined)
Primary Completion Date
June 2013 (Actual)
Study Completion Date
June 2013 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Oslo University Hospital
Collaborators
Norwegian School of Sport Sciences, Gjensidigestiftelsen, The Research Council of Norway

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this study is to determine the feasibility and effect of a program including information, counseling and an individualized physical activity program on physical and psychological health during and after chemotherapy in patients with testicular cancer. It is hypothesized that the patients are able to complete the intervention with individual adjustments.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Testicular Cancer
Keywords
Physical activity, Testicular cancer, Chemotherapy, Feasibility

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
13 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Physical activity counseling
Arm Type
Experimental
Intervention Type
Behavioral
Intervention Name(s)
Physical activity counseling
Primary Outcome Measure Information:
Title
Muscle strength, 1RM (one-repetition-maximum)
Description
Change in 1RM from baseline to post-intervention and follow-up
Time Frame
Baseline (0 weeks), post-intervention (9-12 weeks) and follow-up (24 weeks)
Secondary Outcome Measure Information:
Title
Cardio respiratory fitness (VO2max)
Description
Change in VO2max from baseline to post-intervention and follow-up
Time Frame
Baseline (0 week), post-intervention (9-12 weeks) and follow-up (24 weeks)
Title
Body composition (Lean body mass and fat mass)
Description
Change in body composition from baseline to post-intervention and follow-up
Time Frame
Baseline (0 week), post-intervention (9-12 weeks) and follow-up (24 weeks)
Title
Metabolic disease markers (blood pressure, body mass index, glucose, high density lipoprotein cholesterol, triglycerides)
Description
Change in metabolic disease markers from baseline to post-intervention and follow-up
Time Frame
Baseline (0 week), post-intervention (9-12 weeks) and follow-up (24 weeks)
Title
C-reactive protein (CRP)
Description
Change in CRP from baseline to post-intervention and follow-up
Time Frame
Baseline (0 week), post-intervention (9-12 weeks) and follow-up (24 weeks)
Title
Creatinkinase (CK)
Description
Change in CK from baseline to post-intervention and follow-up
Time Frame
Baseline (0 week), post-intervention (9-12 weeks) and follow-up (24 weeks)
Title
Creatinkinase - MB (CK-MB)
Description
Change in CK-MB from baseline to post-intervention and follow-up
Time Frame
Baseline (0 week), post-intervention (9-12 weeks) and follow-up (24 weeks)
Title
Myoglobin
Description
Change in myoglobin from baseline to post-intervention and follow-up
Time Frame
Baseline (0 week), post-intervention (9-12 weeks) and follow-up (24 weeks)
Title
Work status
Description
Change in work status from baseline to post-intervention and follow-up
Time Frame
Baseline (0 week), post-intervention (9-12 weeks) and follow-up (24 weeks)
Title
Fatigue
Description
Change in fatigue from baseline to post-intervention and follow-up
Time Frame
Baseline (0 week), post-intervention (9-12 weeks) and follow-up (24 weeks)
Title
Anxiety and depression
Description
Change in anxiety and depression from baseline to post-intervention and follow-up
Time Frame
Baseline (0 week), post-intervention (9-12 weeks) and follow-up (24 weeks)
Title
Quality of life
Description
Change in quality of life from baseline to post-intervention and follow-up
Time Frame
Baseline (0 week), post-intervention (9-12 weeks) and follow-up (24 weeks)

10. Eligibility

Sex
Male
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Seminoma/non-seminoma Stage II-IV 3-4 BEP(bleomycin,etoposide and cisplatin)or 4 EP(etoposide and cisplatin) > 18 years Capable of reading and writing Norwegian Exclusion Criteria: Conditions of a severity that contraindicate exercise without adjusted actions Mentally incompetent conditions Conditions of a severity that complicates the ability to participate in a supervised training program
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Lene Thorsen, PhD
Organizational Affiliation
Oslo universty hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Oslo university hospital
City
Oslo
Country
Norway

12. IPD Sharing Statement

Citations:
PubMed Identifier
28619116
Citation
Thorsen L, Kirkegaard C, Loge JH, Kiserud CE, Johansen ML, Gjerset GM, Edvardsen E, Hamre H, Ikdahl T, Fossa SD. Feasibility of a physical activity intervention during and shortly after chemotherapy for testicular cancer. BMC Res Notes. 2017 Jun 15;10(1):214. doi: 10.1186/s13104-017-2531-y.
Results Reference
derived

Learn more about this trial

Physical Activity and Testicular Cancer

We'll reach out to this number within 24 hrs